Status:
UNKNOWN
Haploidentical Transplantation in Severe Aplastic Anemia
Lead Sponsor:
Wu Xiaoxiong
Conditions:
Severe Aplastic Anemia
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a prospective case-control study on SAA patients treated with HSCT, order to further discuss and assess the safety, feasibility and effectiveness of HFD-HSCT which performed with reduced-inten...
Eligibility Criteria
Inclusion
- (i) Diagnosis of SAA, very SAA or SAA and paroxysmal nocturnal hemoglobinuria (PNH) according to the International Aplastic Anemia Study Group; (ii) SAA patients no response to previous IST; (iii) adequate performance status \[Eastern Cooperative Oncology Group (ECOG) score 0-2\].
Exclusion
- (i) Congenital forms of aplastic anemia; (ii)Patients with any severe pulmonary, cardiac, liver, or renal diseases or active infection.
Key Trial Info
Start Date :
July 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03246178
Start Date
July 10 2017
End Date
December 1 2020
Last Update
August 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hematology, 304th Clinical Division, Chinese PLA General Hospital
Beijing, China, 100048